ASCO 2011 - American Society of Clinical Oncology - June 2011 - Chicago
John Theurer Cancer Center researchers shared 14 leading edge studies at recent ASCO meeting
July 18, 2011, Physorg.com
More highlights from ASCO
June 7, 2011, The pharma letter
Improved survival in chronic myeloid leukemia (CML) since introduction of imatinib therapy: A single-institution experience in 1,570 patients referred within 1 month from diagnosis
June 6, 2011, ASCO 2011
A new symptom measure in chronic myeloid leukemia
June 6, 2011, ASCO 2011
Model-based prediction of patient-specific residual disease levels for imatinib-treated chronic myeloid leukemia
June 6, 2011, ASCO 2011
Disease management and treatment of chronic myeloid leukemia (CML): Experience from the patient (pt) perspective
June 6, 2011, ASCO 2011
July 18, 2011, Physorg.com
More highlights from ASCO
June 7, 2011, The pharma letter
Improved survival in chronic myeloid leukemia (CML) since introduction of imatinib therapy: A single-institution experience in 1,570 patients referred within 1 month from diagnosis
June 6, 2011, ASCO 2011
A new symptom measure in chronic myeloid leukemia
June 6, 2011, ASCO 2011
Model-based prediction of patient-specific residual disease levels for imatinib-treated chronic myeloid leukemia
June 6, 2011, ASCO 2011
Disease management and treatment of chronic myeloid leukemia (CML): Experience from the patient (pt) perspective
June 6, 2011, ASCO 2011
